Seah H. Lim - 09 Oct 2022 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Director
Signature
Seah H. Lim
Issuer symbol
EMMA
Transactions as of
09 Oct 2022
Net transactions value
+$1,320,010
Form type
4
Filing time
19 Dec 2023, 19:44:30 UTC
Previous filing
06 Oct 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $2,794 +25,400 +66% $0.1100 63,900 09 Oct 2022 Direct
transaction EMMA Common stock, $0.001 par value Purchase $24,867 +92,100 +144% $0.2700 156,000 25 Aug 2023 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $3,000 +20,000 +13% $0.1500 176,000 30 Aug 2023 Direct
transaction EMMA Common stock, $0.001 par value Purchase $255 +1,700 +0.97% $0.1500 177,700 05 Sep 2023 Direct
transaction EMMA Common stock, $0.001 par value Sale $660 -6,000 -3.4% $0.1100 171,700 15 Dec 2023 Direct
transaction EMMA Common stock, $0.001 par value Other $1,289,754 +4,447,426 +2590% $0.2900 4,619,126 15 Dec 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMMA Promissory Note due 9/16/2025 Other -240,000 -100% 0 15 Dec 2023 Common Stock 240,000 $0.2900 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.20 to $0.27, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
F2 The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation.
F3 Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above.
F4 Represent shares previously issuable upon maturity of the Promissory Note due 9/16/2025.